Company: REVB
Filing Date: 2025-01-13
Form Type: DEFA14A
Source: 0000950170-25-004619
Chunk: 1

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-01-13
Form: DEFA14A
Chunk 1
---
 by calling Advantage Proxy toll free at 877-870-8565 or 206-870-8565.

The Special Meeting of Stockholders will take place virtually via a Zoom videoconference. You can access the virtual meeting by using the following link:https://revbproxy.com/special-meeting-1%2F17%2F2025-1. Any stockholder who is unable to join the online meeting can participate by telephone by dialing (929) 205-6099, using the Zoom Meeting ID 818 7130 5249and the Passcode 614116.

For more information on Revelation, please visitwww.RevBiosciences.com.

About Revelation Biosciences, Inc.

Revelation Biosciences, Inc. is a clinical stage life sciences company focused on harnessing the power of trained immunity for the prevention and treatment of disease using its proprietary formulationGemini. Revelation has multiple ongoing programs to evaluate Gemini, including as a prevention for post-surgical infection, as a prevention for acute kidney injury, and for the treatment of chronic kidney disease.

For more information on Revelation, please visitwww.RevBiosciences.com.

Important Information

Revelation has filed a proxy statement with the Securities and Exchange Commission (SEC) in connection with the solicitation of proxies for the Special Meeting of Stockholders. Before making any voting decision, stockholders are urged to read the proxy statement in its entirety, which contains important information. Stockholders may obtain free copies of the proxy statement and other relevant documents at the SEC’s website (www.sec.gov) athttps://www.sec.gov/Archives/edgar/data/1810560/000095017024136402/revb-20241213.htm. For additional information, please contact Advantage Proxy at 877-870-8565 or 206-870-8565.

Forward-Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These forward-looking statements are generally identified by the words "anticipate", "believe", "expect", "estimate", "plan", "outlook", and "project" and other similar expressions. We caution investors that forward-looking statements are based on management’s expectations and are only predictions or statements of current expectations and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from those anticipated by